Mako Robot Sales Drive Stryker’s Orthopedics Business In Second Quarter
Executive Summary
Stryker reported organic growth of 8.5% during the second quarter of 2019 led by 12% growth in the medical and surgical equipment business, 7% growth in neurotechnology and spine revenue, and 6% growth in sales of orthopedic devices, led by the Mako robotic surgery system.
You may also be interested in...
Stryker’s Mako Robot Continues To Bite Orthopedic Surgery Competition
The company said it expected Mako to continue to drive market share gains in hip and knee surgery. Stryker sold 51 Mako robotic orthopedic surgery systems in the third quarter, bringing the total installed base to 772.
Stryker Closes Gap With Competitors In Strategic Spinal Robotics Acquisition
Stryker is acquiring point-of-care imaging company Mobius Imaging and spine robotics company Cardan Robotics in a deal worth up to $500m.
Zimmer Biomet Continues Turnaround Lead by ROSA Robot
Zimmer Biomet’s net sales were up 1.2% year-over-year in the second quarter. CEO Bryan Hanson said the ROSA Knee robotic surgery system is performing even better than expected since it launched earlier this year, and is expected to be an important revenue-driver in the future.